We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

19 hedge funds and large institutions have $331K invested in LakeShore Biopharma Warrants in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more capital invested

Capital invested by funds: $196K → $331K (+$135K)

6% more funds holding

Funds holding: 18 → 19 (+1)

0.55% more ownership

Funds ownership: 2.15% → 2.7% (+0.55%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
1
Reduced
1
Closed
–
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$41K
2
CS
Clear Street
New York
+$4

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$77
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Athos Capital
Hong Kong
$132K – – –
LP
2
LMR Partners
United Kingdom
$42K – – –
Toronto Dominion Bank
3
Toronto Dominion Bank
Ontario, Canada
$41.8K +$41K +1,048,320 New
VAM
4
Valliance Asset Management
Hong Kong
$29.9K – – –
Jane Street
5
Jane Street
New York
$19.9K – – –
FC
6
Finepoint Capital
Massachusetts
$19.6K – – –
BCL
7
Bracebridge Capital LLC
Massachusetts
$9.27K – – –
Calamos Advisors
8
Calamos Advisors
Illinois
$5.32K – – –
QGA
9
Q Global Advisors
Texas
$5K – – –
WA
10
Whitebox Advisors
Minnesota
$4.99K – – –
TSS
11
Two Sigma Securities
New York
$4.19K -$77 -1,970 -2%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4K – – –
Walleye Capital
13
Walleye Capital
New York
$3.79K – – –
SCM
14
Saba Capital Management
New York
$3.55K – – –
CF
15
Cantor Fitzgerald
New York
$3.07K – – –
CS
16
Clear Street
New York
$1.9K +$4 +100 +0.2%
AA
17
Ancora Advisors
Ohio
$201 – – –
HIM
18
HGC Investment Management
Ontario, Canada
$200 – – –

LSBPW Hedge Fund Activity: Q2 2025 in Review

19 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q2 2025, worth a combined $331K — up 69% from $196K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LSBPW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $41K. The largest seller was Two Sigma Securities, cutting an estimated $77.

  • 19 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q2 2025, up from 18 in Q1 2025.
  • Funds reported $331K of LakeShore Biopharma Warrants stock for Q2 2025, up 69% quarter-over-quarter.
  • 1 fund opened new LakeShore Biopharma Warrants positions in Q2 2025 and 0 closed out, a net change of +1 holder.
  • The largest LakeShore Biopharma Warrants buyer in Q2 2025 was Toronto Dominion Bank, an estimated $41K added.
  • The largest LakeShore Biopharma Warrants seller in Q2 2025 was Two Sigma Securities, an estimated $77 sold.

Based on aggregated 13F filings for Q2 2025.